HYGEIA HEALTH (06078) announced that the Group expects its 2025 revenue to be approximately RMB 4.0 to 4.05 billion, representing a year-on-year decrease of about 9% to 10%.

Net profit is anticipated to be approximately RMB 140 to 200 million, a decline of roughly 66% to 76% compared to the previous year, primarily impacted by goodwill impairment.

Adjusted net profit is projected to be around RMB 450 to 490 million, down approximately 19% to 25% year-on-year.

Net cash generated from operating activities is expected to be approximately RMB 940 million to 1.0 billion, marking an increase of about 33% to 41% compared to the prior year.

The announcement stated that the decreases in revenue, net profit, and non-IFRS adjusted net profit were mainly due to industry and macroeconomic influences, coupled with increased start-up costs and depreciation and amortization expenses for the Group's newly opened hospitals.

The decline in the Group's net profit for the year ended December 31, 2025, aside from the factors mentioned above, was also primarily attributable to a goodwill impairment provision for Etern Group Ltd.

In determining the necessity and amount of the relevant impairment and provision, the Company has carefully evaluated the Group's operational and financial performance as well as the future prospects of its business.

The actual impairment and provision amounts are still subject to further assessment by the Company before being finalized.